Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1591

1.

Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity.

Goto T, Arai Y, Shibata T, Oyama T, Yoshida A.

Virchows Arch. 2019 Aug 5. doi: 10.1007/s00428-019-02623-8. [Epub ahead of print]

PMID:
31385070
2.

Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.

Hirotsu Y, Yokoyama H, Amemiya K, Hagimoto T, Daimon H, Hosaka K, Oyama T, Mochizuki H, Omata M.

Cancer Sci. 2019 Aug 1. doi: 10.1111/cas.14155. [Epub ahead of print]

3.

Is Additional Surgery Always Sufficient for Preventing Recurrence After Endoscopic Submucosal Dissection with Curability C-2 for Early Gastric Cancer?

Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Nakamura T, Nakaya N, Shimosegawa T, Masamune A.

Ann Surg Oncol. 2019 Jul 24. doi: 10.1245/s10434-019-07579-2. [Epub ahead of print]

PMID:
31342376
4.

Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.

Kasahara N, Kaira K, Yamaguchi K, Masubuchi H, Tsurumaki H, Hara K, Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T.

Lung Cancer. 2019 Aug;134:180-186. doi: 10.1016/j.lungcan.2019.06.009. Epub 2019 Jun 11.

PMID:
31319979
5.

Histopathological changes in tumor budding between biopsy and resected specimens from patients treated with preoperative S-1 chemotherapy for oral cancer.

Seki-Soda M, Sano T, Koshi H, Yokoo S, Oyama T.

J Oral Pathol Med. 2019 Jul 16. doi: 10.1111/jop.12923. [Epub ahead of print]

PMID:
31310349
6.

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.

Kurozumi S, Kaira K, Matsumoto H, Hirakata T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu A, Oyama T, Sloan EK, Kurosumi M, Fujii T, Shirabe K.

Breast Cancer Res Treat. 2019 Jul 9. doi: 10.1007/s10549-019-05341-6. [Epub ahead of print]

PMID:
31290053
7.

[A Case of Histiocytoid Breast Carcinoma Accompanied by Multiple Axillary Lymph Node Metastases].

Terakawa H, Gabata R, Ishikawa S, Hirata M, Inokuchi M, Kawashima H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fushida S, Ohta T, Oyama T, Ikeda H.

Gan To Kagaku Ryoho. 2019 Jun;46(6):1049-1051. Japanese.

PMID:
31273173
8.

[Metastatic Lung Tumor from Papillary Thyroid Carcinoma Suspected of Primary Lung Cancer;Report of Two Cases].

Murakami H, Oyama T, Kato R.

Kyobu Geka. 2019 Apr;72(4):314-317. Japanese.

PMID:
31266917
9.

Standard protocol devised by the Japanese Pediatric Impedance Working Group for combined multichannel intraluminal impedance-pH measurements in children.

Fukahori S, Kawahara H, Oyama T, Saito T, Shimono R, Tanaka A, Noda T, Hatori R, Fujino J, Yagi M; Japanese Pediatric Impedance Working Group (Japanese-PIG).

Surg Today. 2019 Jun 18. doi: 10.1007/s00595-019-01833-6. [Epub ahead of print] Review.

PMID:
31214780
10.

Characterization of the human E2F4 promoter region and its response to 12-O-tetradecanoylphorbol-13-acetate.

Hamada H, Goto Y, Arakawa J, Murayama E, Ogawa Y, Konno M, Oyama T, Asai M, Sato A, Tanuma SI, Uchiumi F.

J Biochem. 2019 Jun 14. pii: mvz047. doi: 10.1093/jb/mvz047. [Epub ahead of print]

PMID:
31199460
11.

Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.

Tanuma SI, Shibui Y, Oyama T, Uchiumi F, Abe H.

Biochem Pharmacol. 2019 Jun 6. pii: S0006-2952(19)30223-0. doi: 10.1016/j.bcp.2019.06.004. [Epub ahead of print] Review.

PMID:
31176615
12.

[Hyper-IL-6 syndrome mimicking IgG4-related disease].

Terao T, Yamamoto K, Ikeuchi K, Wakabayashi H, Igawa T, Inoue D, Oda W, Oyama T, Kamoi C, Sumii Y, Shiraishi Y, Yamamoto Y, Niiya D, Shiote Y, Sato Y, Yoshino T, Imajo K.

Rinsho Ketsueki. 2019;60(5):392-397. doi: 10.11406/rinketsu.60.392. Japanese.

PMID:
31168001
13.

Community composition and methane oxidation activity of methanotrophs associated with duckweeds in a fresh water lake.

Iguchi H, Umeda R, Taga H, Oyama T, Yurimoto H, Sakai Y.

J Biosci Bioeng. 2019 May 16. pii: S1389-1723(18)31192-7. doi: 10.1016/j.jbiosc.2019.04.009. [Epub ahead of print]

PMID:
31104899
14.

Comprehensive registry of esophageal cancer in Japan, 2012.

Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, Oyama T, Toh Y, Udagawa H, Uno T; Registration Committee for Esophageal Cancer of the Japan Esophageal Society.

Esophagus. 2019 Jul;16(3):221-245. doi: 10.1007/s10388-019-00674-z. Epub 2019 May 16. No abstract available.

15.

Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric Cancer.

Esaki M, Hatta W, Shimosegawa T, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Gotoda T.

Dig Dis. 2019 May 16:1-11. doi: 10.1159/000499538. [Epub ahead of print]

PMID:
31096243
16.

Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.

Ogawa H, Kaira K, Motegi Y, Yokobori T, Takada T, Katoh R, Osone K, Takahashi R, Katayama C, Oyama T, Kanai Y, Yao T, Asao T, Kuwano H, Shirabe K.

Anticancer Res. 2019 May;39(5):2535-2543. doi: 10.21873/anticanres.13375.

PMID:
31092450
17.

Extension and acceleration of relativistic density functional theory based on transformed density operator.

Ikabata Y, Oyama T, Hayami M, Seino J, Nakai H.

J Chem Phys. 2019 Apr 28;150(16):164104. doi: 10.1063/1.5090523.

PMID:
31042880
18.

Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.

Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M.

Gastroenterology. 2019 Aug;157(2):382-390.e3. doi: 10.1053/j.gastro.2019.04.017. Epub 2019 Apr 20.

19.

Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer.

Nakagomi T, Hirotsu Y, Goto T, Shikata D, Yokoyama Y, Higuchi R, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M.

Cancers (Basel). 2019 Apr 17;11(4). pii: E552. doi: 10.3390/cancers11040552.

20.

Implementation of endoscopic submucosal dissection for early upper gastrointestinal tract cancer after primary experience in colorectal endoscopic submucosal dissection.

Mocker L, Hildenbrand R, Oyama T, Sido B, Yahagi N, Dumoulin FL.

Endosc Int Open. 2019 Apr;7(4):E446-E451. doi: 10.1055/a-0854-3610. Epub 2019 Mar 21.

21.

Comparison of the Effects of Tadalafil and α1-Adrenoceptor Antagonists on Spontaneous Seminal Emission and Electrical Field Stimulation-Induced Seminal Vesicle Contraction in Rats.

Yoshinaga R, Fukui T, Yoshifuji M, Fujimura M, Oyama T, Oka M.

J Sex Med. 2019 May;16(5):680-690. doi: 10.1016/j.jsxm.2019.02.017. Epub 2019 Mar 26.

PMID:
30926520
22.

Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis.

Kurozumi S, Matsumoto H, Kurosumi M, Inoue K, Fujii T, Horiguchi J, Shirabe K, Oyama T, Kuwano H.

Oncol Lett. 2019 Mar;17(3):2647-2656. doi: 10.3892/ol.2019.9938. Epub 2019 Jan 16.

23.

Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.

Tamada K, Nakajima S, Ogawa N, Inada M, Shibasaki H, Sato A, Takasawa R, Yoshimori A, Suzuki Y, Watanabe N, Oyama T, Abe H, Inoue S, Abe T, Yokomizo T, Tanuma S.

Biochem Biophys Res Commun. 2019 Apr 9;511(3):665-670. doi: 10.1016/j.bbrc.2019.01.136. Epub 2019 Feb 27.

PMID:
30826057
24.

Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis.

Dohi O, Hatta W, Gotoda T, Naito Y, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Shimoda R, Yoshida M, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Aoyagi H, Shimosegawa T.

Surg Endosc. 2019 Feb 25. doi: 10.1007/s00464-019-06710-4. [Epub ahead of print]

PMID:
30805782
25.

Modification of cell vulnerability to oxidative stress by N-(3-oxododecanoyl)-L-homoserine-lactone, a quorum sensing molecule, in rat thymocytes.

Nishimura-Danjobara Y, Oyama K, Oyama TM, Yokoigawa K, Oyama Y.

Chem Biol Interact. 2019 Apr 1;302:143-148. doi: 10.1016/j.cbi.2019.02.006. Epub 2019 Feb 16.

PMID:
30779908
26.

Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer.

Kurozumi S, Inoue K, Matsumoto H, Fujii T, Horiguchi J, Oyama T, Kurosumi M, Shirabe K.

Sci Rep. 2019 Feb 7;9(1):1583. doi: 10.1038/s41598-018-38272-1.

27.

An Adult Case of Pulmonary Artery Sling Accompanied by Tracheobronchomalacia.

Imoto S, Satomi R, Watase M, So M, Murakami H, Hosoo S, Miwa I, Fujimoto K, Nukaga S, Yagi K, Oguro S, Oyama T, Kato R, Oyamada Y.

Intern Med. 2019 Jun 1;58(11):1621-1624. doi: 10.2169/internalmedicine.2089-18. Epub 2019 Feb 1.

28.

Multicenter prospective study on the histological diagnosis of gastric cancer by narrow band imaging-magnified endoscopy with and without acetic acid.

Kishino T, Oyama T, Funakawa K, Ishii E, Yamazato T, Shibagaki K, Miike T, Tanuma T, Kuwayama Y, Takeuchi M, Kitamura Y.

Endosc Int Open. 2019 Feb;7(2):E155-E163. doi: 10.1055/a-0806-7275. Epub 2019 Jan 18.

29.

Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.

Hirotsu Y, Mochizuki H, Amemiya K, Ohyama H, Yoshimura D, Amano H, Miura Y, Ashizawa H, Nakagomi K, Takaoka S, Hosoda K, Suzuki Y, Oyama T, Hada M, Kojima Y, Omata M.

Med Oncol. 2019 Jan 29;36(3):23. doi: 10.1007/s12032-019-1246-4.

PMID:
30694393
30.

Molecular subtype switching in early-stage gastric cancers with multiple occurrences.

Takaoka S, Hirotsu Y, Ohyama H, Mochizuki H, Amemiya K, Oyama T, Ashizawa H, Yoshimura D, Nakagomi K, Hosoda K, Suzuki Y, Kojima Y, Omata M.

J Gastroenterol. 2019 Aug;54(8):674-686. doi: 10.1007/s00535-019-01547-z. Epub 2019 Jan 21.

PMID:
30666417
31.

SMARCB1- and vimentin-positive esophageal carcinoma with undifferentiated components, rhabdoid features, and a good prognosis: a case report.

Nagano H, Izumi T, Kawahara E, Oyama T, Goi T.

Surg Case Rep. 2019 Jan 16;5(1):8. doi: 10.1186/s40792-019-0562-4.

32.

Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma.

Takahashi H, Sakakura K, Tada H, Kaira K, Oyama T, Chikamatsu K.

Head Neck. 2019 Jun;41(6):1880-1888. doi: 10.1002/hed.25625. Epub 2019 Jan 12.

PMID:
30636187
33.

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer.

Handa T, Katayama A, Yokobori T, Yamane A, Fujii T, Obayashi S, Kurozumi S, Kawabata-Iwakawa R, Gombodorj N, Nishiyama M, Asao T, Shirabe K, Kuwano H, Oyama T.

Int J Oncol. 2019 Mar;54(3):833-844. doi: 10.3892/ijo.2019.4675. Epub 2019 Jan 4.

34.

Photo-Modification of Melanin by a Mid-infrared Free-electron Laser.

Kawasaki T, Sato A, Tominaga Y, Suzuki Y, Oyama T, Tadokoro M, Tsukiyama K, Nokihara K, Zen H.

Photochem Photobiol. 2019 Jul;95(4):946-950. doi: 10.1111/php.13079. Epub 2019 Feb 7.

PMID:
30613988
35.

Prognostic Impact of β2 Adrenergic Receptor Expression in Surgically Resected Pulmonary Pleomorphic Carcinoma.

Kaira K, Kamiyoshihara M, Kawashima O, Endoh H, Imaizumi K, Sugano M, Tanaka S, Fujita A, Kogure Y, Shimizu A, Oyama T, Asao T, Shimizu K, Mogi A.

Anticancer Res. 2019 Jan;39(1):395-403. doi: 10.21873/anticanres.13125.

PMID:
30591486
36.

Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan.

Abe S, Ishihara R, Takahashi H, Ono H, Fujisaki J, Matsui A, Takahashi A, Goda K, Kawada K, Koike T, Takeuchi M, Tsuji Y, Hirasawa D, Oyama T.

Gastrointest Endosc. 2019 Jun;89(6):1120-1128. doi: 10.1016/j.gie.2018.12.010. Epub 2018 Dec 18.

PMID:
30576649
37.

Recurrence Patterns and Outcomes of Salvage Surgery in Cases of Non-Curative Endoscopic Submucosal Dissection without Additional Radical Surgery for Early Gastric Cancer.

Takizawa K, Hatta W, Gotoda T, Kawata N, Nakagawa M, Takahashi A, Esaki M, Mitoro A, Yamada S, Tanaka K, Matsuda M, Takada J, Oka S, Ito H, Ohnita K, Shimoda R, Hoteya S, Oyama T, Shimosegawa T.

Digestion. 2019;99(1):52-58. doi: 10.1159/000494413. Epub 2018 Dec 14.

PMID:
30554228
38.

Image analysis of the nuclear characteristics of emerin protein and the correlation with nuclear grooves and intranuclear cytoplasmic inclusions in lung adenocarcinoma.

Kobayashi S, Saio M, Fukuda T, Kimura K, Hirato J, Oyama T.

Oncol Rep. 2019 Jan;41(1):133-142. doi: 10.3892/or.2018.6848. Epub 2018 Nov 2.

39.

Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3.

Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M.

Cancers (Basel). 2018 Nov 30;10(12). pii: E478. doi: 10.3390/cancers10120478.

40.

Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer.

Yamada S, Hatta W, Shimosegawa T, Takizawa K, Oyama T, Kawata N, Takahashi A, Oka S, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Nakaya N, Gotoda T.

Gastrointest Endosc. 2019 May;89(5):950-960. doi: 10.1016/j.gie.2018.11.015. Epub 2018 Nov 19.

PMID:
30465769
41.

A case report of granulomatous polyangiitis complicated by tuberculous lymphadenitis.

Iijima Y, Kobayashi Y, Uchida Y, Tsutsui T, Kakizaki Y, Naganuma T, Tsukamoto K, Oyama T, Miyashita Y.

Medicine (Baltimore). 2018 Oct;97(43):e12430. doi: 10.1097/MD.0000000000012430.

42.

Relationship between formalin reagent and success rate of targeted sequencing analysis using formalin fixed paraffin embedded tissues.

Amemiya K, Hirotsu Y, Oyama T, Omata M.

Clin Chim Acta. 2019 Jan;488:129-134. doi: 10.1016/j.cca.2018.11.002. Epub 2018 Nov 3.

PMID:
30395866
43.

Direct visualization of DNA baton pass between replication factors bound to PCNA.

Mayanagi K, Ishino S, Shirai T, Oyama T, Kiyonari S, Kohda D, Morikawa K, Ishino Y.

Sci Rep. 2018 Nov 1;8(1):16209. doi: 10.1038/s41598-018-34176-2.

44.

Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.

Ooi A, Inokuchi M, Horike SI, Kawashima H, Ishikawa S, Ikeda H, Nakamura R, Oyama T, Dobashi Y.

Hum Pathol. 2019 Mar;85:33-43. doi: 10.1016/j.humpath.2018.10.017. Epub 2018 Oct 30.

PMID:
30385370
45.

Chromosome 3p Loss-Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma.

Hsieh JJ, Le VH, Oyama T, Ricketts CJ, Ho TH, Cheng EH.

J Clin Oncol. 2018 Oct 29:JCO2018792549. doi: 10.1200/JCO.2018.79.2549. [Epub ahead of print]

PMID:
30372397
46.

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling.

Horigome E, Fujieda M, Handa T, Katayama A, Ito M, Ichihara A, Tanaka D, Gombodorj N, Yoshiyama S, Yamane A, Yamada K, Horiguchi J, Shinozuka K, Oyama T, Nishiyama M, Rokudai S.

Oncotarget. 2018 Oct 2;9(77):34554-34566. doi: 10.18632/oncotarget.26177. eCollection 2018 Oct 2.

47.

Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.

Kaira K, Kawashima O, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Sugano M, Yamamoto R, Osaki T, Tanaka S, Fujita A, Imai H, Kogure Y, Seki Y, Shimizu K, Mogi A, Shitara Y, Oyama T, Kanai Y, Asao T.

Hum Pathol. 2019 Feb;84:142-149. doi: 10.1016/j.humpath.2018.09.020. Epub 2018 Oct 6.

PMID:
30300664
48.

Fluorescence Tumor-Imaging Using a Thermo-Responsive Molecule with an Emissive Aminoquinoline Derivative.

Araki T, Fuchi Y, Murayama S, Shiraishi R, Oyama T, Aso M, Aoki I, Kobayashi S, Yamada KI, Karasawa S.

Nanomaterials (Basel). 2018 Oct 2;8(10). pii: E782. doi: 10.3390/nano8100782.

49.

High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.

Suzuki M, Yokobori T, Gombodorj N, Yashiro M, Turtoi A, Handa T, Ogata K, Oyama T, Shirabe K, Kuwano H.

J Surg Oncol. 2018 Nov;118(6):966-974. doi: 10.1002/jso.25217. Epub 2018 Sep 9.

PMID:
30260476
50.

Comparing protein and mRNA expressions of the human epidermal growth factor receptor family in estrogen receptor-positive breast cancer.

Kurozumi S, Yamaguchi Y, Matsumoto H, Inoue K, Kurosumi M, Oyama T, Horiguchi J, Fujii T, Shirabe K.

Med Mol Morphol. 2019 Jun;52(2):90-98. doi: 10.1007/s00795-018-0206-y. Epub 2018 Sep 27.

PMID:
30259117

Supplemental Content

Support Center